Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues
| Class:Id | LiteratureReference:9704124 |
|---|---|
| _displayName | Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues |
| _timestamp | 2020-10-07 13:54:06 |
| author | [Person:9704141] Hegde, Sharath S [Person:9704026] Pulido-Rios, M Teresa [Person:9704165] Luttmann, Mark A [Person:9704044] Foley, James J [Person:9703994] Hunsberger, Gerald E [Person:9704201] Steinfeld, Tod [Person:9704194] Lee, TaeWeon [Person:9704170] Ji, Yuhua [Person:9704027] Mammen, Mathai M [Person:9704007] Jasper, Jeffrey R |
| created | [InstanceEdit:9704054] Jassal, Bijay, 2020-10-07 |
| journal | Pharmacol Res Perspect |
| pages | e00400 |
| pubMedIdentifier | 29736245 |
| title | Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues |
| volume | 6 |
| year | 2018 |
| (literatureReference) | [Reaction:9704253] CHRM3 binds CHRM3 antagonists [Homo sapiens] [Reaction:9704263] CHRM5 binds CHRM5 antagonists [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues (9704124)
